Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Macrophage Regulation of Ozone-Induced Lung Inflammation
NCT05773001Phase 1Recruiting
- Start
- May 2023
- Primary completion
- May 2028
- Countries
- 1
01
Overview
Phase 1, open-label trial (3 cohorts). Primary endpoint: Change in the abundance of monocyte-derived alveolar macrophages. Started May 2023; status: recruiting.
Beyond the preview
Go deeper on NCT05773001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05773001.